Category Archives: Featured

Progress of ICONIC Residences in Dubai: Milestones Achieved

ICONIC Residences reaches key construction milestones, MERED highlights market confidence

Dubai, UAE – 26 March 2026: MERED, the award-winning real estate developer, has reported significant progress on ICONIC Residences Design by Pininfarina, one of Dubai’s most ambitious premium projects. Construction is advancing steadily across multiple phases, with fully mobilised teams achieving key milestones in structural works, MEP systems, interior fit-outs, and material coordination. The update underscores the resilience of Dubai’s off-plan property market, supported by government measures that safeguard the industry and ensure large-scale developments remain on schedule.

Continue reading Progress of ICONIC Residences in Dubai: Milestones Achieved

Primark Launches First Store in Dubai Mall

PRIMARK OPENS ITS FIRST STORE IN DUBAI IN PARTNERSHIP WITH ALSHAYA GROUP

  • Primark has officially opened its doors in The Dubai Mall, marking the retailer’s second store in the Middle East and first store in the UAE
  • In partnership with Alshaya Group, Primark set to open an additional two stores in Dubai in April and May, followed by Bahrain and Qatar later this year.

Kuwait | 26 March 2026 10:00 GST: Today, international fashion retailer Primark, in partnership with Alshaya Group, made its highly anticipated UAE debut with the opening of its first store in the iconic Dubai Mall. The opening marks an important step in the retailer’s international expansion as it enters its 19th market globally.

The store was officially opened with a ribbon-cutting ceremony by John Hadden, CEO of Alshaya Group, Her Excellency, Alison Milton, the Irish Ambassador to the United Arab Emirates, Qatar & Kuwait, and Ghansham Pindoria, Vice President of Primark Middle East, marking the exciting entry of the brand in Dubai.

Continue reading Primark Launches First Store in Dubai Mall

Piyush Goyal Launches $24M CSR by Malabar Gold for Education

India Union Minister Piyush Goyal Unveils Malabar Gold & Diamonds’ USD 24 Million CSR Initiative for FY 2026–27

Malabar Gold & Diamonds, the world’s fifth-largest retail jewellery group and a responsible jewellery brand, has today announced their CSR initiatives worth USD 24 Million for the financial year 2026-27 held at Dr. Ambedkar International Centre in New Delhi in the presence of Shri Piyush Goyal, India Union Minister for Commerce and Industry.

At the CSR initiative, the Union Minister inaugurated the distribution of educational scholarships for 33,000 female students across India. The event was attended by Malabar Group Chairman Mr. M.P. Ahammad, Malabar Gold & Diamonds Managing Director – India Operations Mr. O. Asher, Malabar Group Executive Directors Mr. Nishad A.K. and Mr. Abdulla Ibrahim, Kerala House Resident Commissioner Mr. Puneet Kumar, IAS, Pratham CEO Ms. Rukmini Banerji, and Thanal Chairman Dr. Idris, among others.

Continue reading Piyush Goyal Launches $24M CSR by Malabar Gold for Education

Orforglipron vs. Semaglutide: A New Era in Diabetes Treatment

Lilly’s oral GLP-1, orforglipron, delivered superior blood sugar control and weight loss compared to oral semaglutide in head-to-head type 2 diabetes trial published in The Lancet

  • For the primary endpoint, orforglipron 36 mg lowered A1C by 2.2% vs. 1.4% with oral semaglutide 14 mg in ACHIEVE-3
  • In a key secondary endpoint, participants on orforglipron 36 mg lost 19.7 lbs (9.2%) compared to 11.0 lbs (5.3%) with oral semaglutide 14 mg, representing a 73.6% greater relative weight loss
  • Lilly has submitted orforglipron to regulators in over 40 countries, with potential U.S. action for obesity in Q2 2026

INDIANAPOLIS, March 24, 2026 — Eli Lilly and Company (NYSE: LLY) today announced detailed results from ACHIEVE-3, the first head-to-head Phase 3 trial evaluating the safety and efficacy of orforglipron, a small molecule oral GLP-1 without food or water restrictions, compared with oral semaglutide in adults with type 2 diabetes inadequately controlled with metformin. The 52-week trial enrolled 1,698 participants across four treatment arms: orforglipron 12 mg and 36 mg, and oral semaglutide 7 mg and 14 mg. In ACHIEVE-3, orforglipron outperformed oral semaglutide across the primary and all key secondary endpoints, delivering significantly greater improvements in A1C and weight.1,2 The results were published today in The Lancet.

Continue reading Orforglipron vs. Semaglutide: A New Era in Diabetes Treatment

Malabar Charitable Trust with Pratham Education Foundation to Strengthen Micro Learning Centres for Underprivileged Children

Malabar Charitable Trust, the CSR wing of Malabar Group, has partnered with the Pratham Education Foundation to further strengthen its Micro Learning Centres (MLCs) initiative aimed at rehabilitating and supporting the education of underprivileged children across India.

A Memorandum of Understanding (MoU) was signed between Malabar Charitable Trust, social welfare organisation Thanal, and Pratham Education Foundation at the Malabar Group headquarters in Kozhikode.

The signing ceremony was attended by Mr. M. P. Ahammad, Chairman of Malabar Group Mr. Asher O, Managing Director – India Operations, Malabar Gold & Diamonds;  Ms. Preeti Pandey, Program Manager at Pratham Education Foundation; Dr. V. Idrees, Chairman of Thanal, Mr. Nishad A. K., Executive Director of Malabar Group; and Mr. U. V. Jose, Head – Public Affairs at Malabar Group.

Continue reading Malabar Charitable Trust with Pratham Education Foundation to Strengthen Micro Learning Centres for Underprivileged Children